Moving the needle of CAR-T beyond oncology
Drug Discovery World
FEBRUARY 27, 2024
DDW’s Megan Thomas speaks with Dr Blythe Sather, Vice President and Head of Research at Tune Therapeutics, about how genetic tuning will transform the reach for CAR-T therapies, the different diseases that can benefit, and the disruptive technology making this happen. MT: What is genetic tuning?
Let's personalize your content